250 related articles for article (PubMed ID: 31454852)
1. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.
Zhang X; Lu H; Xie S; Wu C; Guo Y; Xiao Y; Zheng S; Zhu H; Zhang Y; Bai Y
Br J Pharmacol; 2019 Dec; 176(24):4745-4759. PubMed ID: 31454852
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway.
Bai Y; Lu H; Wu C; Liang Y; Wang S; Lin C; Chen B; Xia P
Biochem Pharmacol; 2014 Dec; 92(3):484-93. PubMed ID: 25219324
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function.
Liu S; Zhao M; Zhou Y; Wang C; Yuan Y; Li L; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
Phytomedicine; 2019 Apr; 57():223-235. PubMed ID: 30785018
[TBL] [Abstract][Full Text] [Related]
7. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
8. Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro.
Chiang CK; Sheu ML; Lin YW; Wu CT; Yang CC; Chen MW; Hung KY; Wu KD; Liu SH
Br J Pharmacol; 2011 Jun; 163(3):586-97. PubMed ID: 21265825
[TBL] [Abstract][Full Text] [Related]
9. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
[TBL] [Abstract][Full Text] [Related]
10. Early differential expression of oncostatin M in obstructive nephropathy.
Elbjeirami WM; Truong LD; Tawil A; Wang W; Dawson S; Lan HY; Zhang P; Garcia GE; Wayne Smith C
J Interferon Cytokine Res; 2010 Jul; 30(7):513-23. PubMed ID: 20626292
[TBL] [Abstract][Full Text] [Related]
11. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling.
Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y
J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
13. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
14. α2AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction.
Kanno Y; Kawashita E; Kokado A; Kuretake H; Ikeda K; Okada K; Seishima M; Ueshima S; Matsuo O; Matsuno H
Sci Rep; 2014 Aug; 4():5967. PubMed ID: 25095732
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.
Zhang B; Liu P; Zhou Y; Chen Z; He Y; Mo M; Dai G; Xia W; Du Y; Liu Y; Chen X
Life Sci; 2019 Apr; 223():29-37. PubMed ID: 30862567
[TBL] [Abstract][Full Text] [Related]
16. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.
Li Y; Sun Y; Liu F; Sun L; Li J; Duan S; Liu H; Peng Y; Xiao L; Liu Y; Xi Y; You Y; Li H; Wang M; Wang S; Hou T
PLoS One; 2013; 8(6):e66356. PubMed ID: 23825538
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition.
Tasanarong A; Kongkham S; Thitiarchakul S; Eiam-Ong S
J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S10-8. PubMed ID: 22619901
[TBL] [Abstract][Full Text] [Related]
19. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid attenuates renal fibrosis through the induction of autophagy.
Kawaoka K; Doi S; Nakashima A; Yamada K; Ueno T; Doi T; Masaki T
Clin Exp Nephrol; 2017 Oct; 21(5):771-780. PubMed ID: 27928635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
